Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 8
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Clinical/translational cancer immunotherapy
Original research
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
Online download statistics by month:
Online download statistics by month: August 2021 to February 2024
Abstract
Full
Pdf
Aug 2021
187
187
64
Sep 2021
228
229
100
Oct 2021
106
106
26
Nov 2021
94
94
30
Dec 2021
168
168
23
Jan 2022
56
59
30
Feb 2022
106
109
18
Mar 2022
54
54
18
Apr 2022
59
60
19
May 2022
64
64
20
Jun 2022
63
63
27
Jul 2022
58
59
18
Aug 2022
57
57
11
Sep 2022
65
65
36
Oct 2022
39
39
17
Nov 2022
46
48
35
Dec 2022
25
25
5
Jan 2023
32
32
16
Feb 2023
56
56
13
Mar 2023
21
22
20
Apr 2023
23
23
19
May 2023
26
26
13
Jun 2023
30
30
10
Jul 2023
23
23
16
Aug 2023
21
21
5
Sep 2023
17
17
11
Oct 2023
27
27
17
Nov 2023
36
36
15
Dec 2023
26
27
11
Jan 2024
42
43
32
Feb 2024
27
28
22
Total
1882
1897
717
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?